[P2] A

[P2-082-A] African Swine Fever Vaccine Candidate ASFV-G-ΔI177L/ΔLVR Protective against Homologous Virulent Challenge and Long-term Maintenance of Vaccine Antibodies

sujin lee¹, Yeonji Kim², SunA Choi¹, Keun Seung Ahn¹, SeYoung lee¹, Xinghua Zheng¹, Do Soon Kim¹, Wonjun Kim², Youngwoo Shin², So-Jeong Kim², Sua Choi², Dong Seob Tark³, Seong Cheol Moon¹, Weonhwa Jheong², *Jung Hyang Sur¹ (1. Komipharm International Co.,Ltd (Korea), 2. Ministry of Environment (Korea), 3. Jeonbuk National University (Korea))

Keywords:

ASF,African swine fever,Live attenuated virus,vaccine,ASFV-G-ΔI177L,USDA,sow,safety